AMONGAgreement and Plan of Merger • February 18th, 2000 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Delaware
B. OPTIONS TO EXTEND LEASE - Provided that Tenant is not, and has not been, in default or in breach of its lease obligations as set forth herein, Tenant shall have the right to extend the terms of this Lease for two (2) additional terms of five (5)...Lease Agreement • August 14th, 1998 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Vermont
AMENDMENT NO. 3 TO THE SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
101 Huntington Avenue Boston, Massachusetts 02199 (the "Building") SUBLEASE -------- March 15, 2000Creative Biomolecules Inc • May 5th, 2000 • Biological products, (no disgnostic substances)
3 - 4 Applications and the patents and applications that have been prosecuted in Stryker's name during the period from May 17, 1991 to October 31, 1996 as Future Patents and Applications (as defined below), a list of which is set forth in Schedule I...Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
1 EXHIBIT 10.54 SUBSCRIPTION AGREEMENT DATED AS OF MAY 22, 1998 BY AND BETWEEN CREATIVE BIOMOLECULES, INC.Subscription Agreement • June 5th, 1998 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.8 STRYKER IRREVOCABLE LICENSE AGREEMENTLicense Agreement • March 13th, 2000 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.11 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 30th, 1999 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
2 - 3 2.2 Registration Rights Agreement. The Second Amended and Restated Registration Rights Agreement, dated as of May 24, 1996, by and among the Company and various holders of the Company's securities (the "Registration Rights Agreement") shall have...Restricted Stock Purchase Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Massachusetts
FIRST AMENDMENT August 10, 1998Creative Biomolecules Inc • November 13th, 1998 • Biological products, (no disgnostic substances)
1 CREATIVE BIOMOLECULES, INC. HAS OMITTED FROM THIS EXHIBIT 10.10 PORTIONS OF THE AGREEMENT FOR WHICH CREATIVE BIOMOLECULES, INC. HAS REQUESTED CONFIDENTIAL TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE PORTIONS OF THE AGREEMENT FOR WHICH...Master Restructuring Agreement • March 30th, 1999 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • New York
Page 1 of 4 FOURTH AMENDMENT Amendment of Lease made this 10th day of April, 1997, by and between WRC Properties, Inc., 730 Third Avenue, New York, New York 10017 (hereinafter with its successors and assigns called the "Lessor"), and Creative...Creative Biomolecules Inc • August 12th, 1997 • Biological products, (no disgnostic substances) • Massachusetts
Page 1 of 4 THIRD AMENDMENT Amendment of Lease made this 10th day of April, 1997, by and between WRC Properties, Inc., 730 Third Avenue, New York, New York 10017 (hereinafter with its successors and assigns called the "Lessor"), and Creative...Creative Biomolecules Inc • August 12th, 1997 • Biological products, (no disgnostic substances) • Massachusetts
Exhibit 10.38 FINOVA TECHNOLOGY FINANCE, INC. MASTER LEASE AGREEMENT DATED OCTOBER 6, 1997 Lessor: FINOVA Technology Finance, Inc. Lessee: Creative BioMolecules, Inc. 10 Waterside Drive 45 South Street Farmington, CT 06032 Hopkinton, MA 01748 1....1 • March 30th, 1998 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Arizona
EXHIBIT 10.2 ------------ PROMISSORY NOTE ---------------Creative Biomolecules Inc • May 5th, 2000 • Biological products, (no disgnostic substances)
CREATIVE IRREVOCABLE LICENSE AGREEMENTIrrevocable License Agreement • March 13th, 2000 • Creative Biomolecules Inc • Biological products, (no disgnostic substances) • Delaware
1 EXHIBIT 10.37 CREATIVE BIOMOLECULES, INC. HAS OMITTED FROM THIS EXHIBIT 10.37 PORTIONS OF THE AGREEMENT FOR WHICH CREATIVE BIOMOLECULES, INC. HAS REQUESTED CONFIDENTIAL TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE PORTIONS OF THE...Collaboration and License Agreement • March 31st, 1997 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
Exhibit 10.16 PARTIAL LEASE TERMINATION AGREEMENT AND AMENDMENT TO LEASE This Partial Lease Termination Agreement and Amendment to Lease (this "Agreement") is hereby entered into as of the 28th day of February, 1999 (the "Early Termination Date") by...Partial Lease Termination Agreement • March 13th, 2000 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
ASSIGNMENT ----------Creative Biomolecules Inc • March 13th, 2000 • Biological products, (no disgnostic substances)
Creative BioMolecules, Inc., a Delaware corporation, having a place of business at 35 South Street, Hopkinton, MA, in consideration of One Dollar and other valuable consideration paid to it by Stryker Corporation, a Michigan corporation, having a principal place of business at 2725 Fairfield Road, Kalamazoo, MI, the receipt of which is hereby acknowledged, does hereby sell, assign and transfer unto said Stryker Corporation, its successors and assigns, its entire right, title and interest for the United States of America and all foreign countries, including all rights of priority under the International Convention for the Protection of Industrial Property, in the inventions and improvements disclosed in the U.S., foreign, and PCT applications listed in Schedule A attached hereto, and in all Letters Patent of the United States and all foreign countries which have been or shall be granted on said inventions, or any parts thereof, or on said applications, or any divisions, continuations, r
1 CREATIVE BIOMOLECULES, INC. HAS OMITTED FROM THIS EXHIBIT 10.38 PORTIONS OF THE AGREEMENT FOR WHICH CREATIVE BIOMOLECULES, INC. HAS REQUESTED CONFIDENTIAL TREATMENT FROM THE SECURITIES AND EXCHANGE COMMISSION. THE PORTIONS OF THE AGREEMENT FOR WHICH...Amendment Agreement • March 30th, 1999 • Creative Biomolecules Inc • Biological products, (no disgnostic substances)
